The BECLIPSA brand, founded in 2003 (United States), from
126 sister brands
and 17477 competing brands.
BECLIPSA is owned by Celgene, listed on the stock exchange of New York
BECLIPSA belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.